Eli Lilly and Company
The Value Chain Leader serves as the single point of accountability for a product's entire manufacturing commercialization lifecycle, owning the manufacturing CMC strategy and leading the Value Chain Team. This strategic leadership role requires deep pharma development and/or manufacturing knowledge to drive alignment across a matrixed organization without direct authority. The position involves orchestrating cross-functional teams, managing technical agendas, and serving as the primary interface for senior executives regarding commercialization status.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
16% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Principal Engineer, Pharma CMC Manufacturing & Tech Transfer
Varda Space Industries
Director, Technical Operations
Travere Therapeutics
Head of Drug Product Development
Ironwood Pharmaceuticals
Senior Director, CMC Technical Operations, siRNA Therapeutics
Alector
CMC Program Manager
Atrium Therapeutics
Principle I, GRA-CMC
Kyowa Kirin North America, Inc.